Role of the Systemic Inflammatory Response Index in Predicting Disease Severity and Prognosis in Idiopathic Pulmonary Arterial Hypertension

References

• Humbert M, Kovacs G, Hoeper MM, et al. ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618–3731. doi:10.1093/eurheartj/ehac237
   PubMed Web of Science ®Google Scholar
• Thenappan T, Ormiston ML, Ryan JJ, et al. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360:j5492. doi:10.1136/bmj.j5492
   PubMed Web of Science ®Google Scholar
• Rabinovitch M, Guignabert C, Humbert M, et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115(1):165–175. doi:10.1161/CIRCRESAHA.113.301141
   PubMed Web of Science ®Google Scholar
• Quarck R, Nawrot T, Meyns B, et al. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol. 2009;53(14):1211–1218. doi:10.1016/j.jacc.2008.12.038
   PubMed Web of Science ®Google Scholar
• Cerik IB, Dindas F, Koyun E, et al. New prognostic markers in pulmonary arterial hypertension: CRP to albumin ratio and uric acid. Clin Biochem. 2022;100:22–28. doi:10.1016/j.clinbiochem.2021.11.004
   PubMed Web of Science ®Google Scholar
• Chen JY, Griffiths M, Yang J, et al. Elevated interleukin-6 levels predict clinical worsening in pediatric pulmonary arterial hypertension. J Pediatr. 2020;223:164–169
   PubMed Web of Science ®Google Scholar
• Kazimierczyk R, Blaszczak P, Jasiewicz M, et al. Increased platelet content of SDF-1alpha is associated with worse prognosis in patients with pulmonary prterial hypertension. Platelets. 2019;30(4):445–451. doi:10.1080/09537104.2018.1457780
   PubMed Web of Science ®Google Scholar
• Yogeswaran A, Tello K, Lund J, et al. Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters. J Heart Lung Transplant. 2022;41(3):400–410. doi:10.1016/j.healun.2021.10.018
   PubMed Web of Science ®Google Scholar
• Xia Y, Xia C, Wu L, et al. Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults. J Clin Med. 2023;12(3):1128. doi:10.3390/jcm12031128
   PubMed Web of Science ®Google Scholar
• Dziedzic EA, Gąsior JS, Tuzimek A, et al. Investigation of the associations of novel inflammatory biomarkers-Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence. Int J Mol Sci. 2022;23(17):9553. doi:10.3390/ijms23179553
   PubMed Web of Science ®Google Scholar
• Liu X, Ge H, Feng X, et al. The combination of hemogram indexes to predict exacerbation in stable chronic obstructive pulmonary disease. Front Med Lausanne. 2020;7:572435. doi:10.3389/fmed.2020.572435
   PubMed Web of Science ®Google Scholar
• Wang X, Ni Q, Wang J, et al. Systemic inflammation response index is a promising prognostic marker in elderly patients with heart failure: a retrospective cohort study. Front Cardiovasc Med. 2022;9:871031. doi:10.3389/fcvm.2022.871031
   PubMed Web of Science ®Google Scholar
• Hoeper MM, Kramer T, Pan Z, et al. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J. 2017;50(2):1700740. doi:10.1183/13993003.00740-2017
   PubMed Web of Science ®Google Scholar
• Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society Of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30(20):2493–2537. doi:10.1093/eurheartj/ehp297
   PubMed Web of Science ®Google Scholar
• Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American society of echocardiography endorsed by the European association of echocardiography, a registered branch of the European society of cardiology, and the Canadian society of echocardiography. J Am Soc Echocardiogr. 2010;23(7):685–713; quiz 786–8. doi:10.1016/j.echo.2010.05.010
   PubMed Web of Science ®Google Scholar
• Galiè N, Humbert M, Vachiery J-L, et al. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).. Eur Heart J. 2016;37(1):67–119
   PubMed Web of Science ®Google Scholar
• Evans CE, Cober ND, Dai Z, et al. Endothelial cells in the pathogenesis of pulmonary arterial hypertension. Eur Respir J. 2021;58(3):2003957. doi:10.1183/13993003.03957-2020
   PubMed Web of Science ®Google Scholar
• Tang W, Li M, Yangzhong X, et al. Hippo signaling pathway and respiratory diseases. Cell Death Discov. 2022;8(1):213. doi:10.1038/s41420-022-01020-6
   PubMed Web of Science ®Google Scholar
• Wang -R-R, Yuan T-Y, Wang J-M, et al. Immunity and inflammation in pulmonary arterial hypertension: from pathophysiology mechanisms to treatment perspective. Pharmacol Res. 2022;180:106238. doi:10.1016/j.phrs.2022.106238
   PubMed Web of Science ®Google Scholar
• Hu Y, Chi L, Kuebler WM, et al. Perivascular inflammation in pulmonary arterial hypertension. Cells. 2020;9(11):2338. doi:10.3390/cells9112338
   PubMed Web of Science ®Google Scholar
• Stacher E, Graham BB, Hunt JM, et al. Modern age pathology of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186(3):261–272. doi:10.1164/rccm.201201-0164OC
   PubMed Web of Science ®Google Scholar
• Cheng Y-L, Sung S-H, Cheng H-M, et al. Prognostic nutritional index and the risk of mortality in patients with acute heart failure. J Am Heart Assoc. 2017;6(6): doi:10.1161/JAHA.116.004876
   Web of Science ®Google Scholar
• Halade GV, Lee DH. Inflammation and resolution signaling in cardiac repair and heart failure. EBioMedicine. 2022;79:103992. doi:10.1016/j.ebiom.2022.103992
   PubMed Web of Science ®Google Scholar
• Tang X, Wang P, Zhang R, et al. KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression. J Clin Invest. 2022;132(3): doi:10.1172/JCI147191
   Web of Science ®Google Scholar
• Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18(2):134–147. doi:10.1038/nri.2017.105
   PubMed Web of Science ®Google Scholar
• Murray PJ. Immune regulation by monocytes. Semin Immunol. 2018;35:12–18. doi:10.1016/j.smim.2017.12.005
   PubMed Web of Science ®Google Scholar
• Zou H, Zhou N, Huang Y, et al. Phenotypes, roles, and modulation of regulatory lymphocytes in periodontitis and its associated systemic diseases. J Leukoc Biol. 2022;111(2):451–467. doi:10.1002/JLB.3VMR0321-027RRR
   PubMed Web of Science ®Google Scholar
• Taylor S, Dirir O, Zamanian RT, et al. The role of neutrophils and neutrophil elastase in pulmonary arterial hypertension. Front Med Lausanne. 2018;5:217. doi:10.3389/fmed.2018.00217
   PubMed Web of Science ®Google Scholar
• Klinke A, Berghausen E, Friedrichs K, et al. Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinase. JCI Insight. 2018;3(11): doi:10.1172/jci.insight.97530
   PubMed Web of Science ®Google Scholar
• Zhang R, Zhang J, Zhang Y-L, et al. Single-cell transcriptome analysis of peripheral neutrophils from patients with idiopathic pulmonary arterial hypertension. Hypertension. 2023;80(8):1784–1794. doi:10.1161/HYPERTENSIONAHA.123.21142
   PubMed Web of Science ®Google Scholar
• de Barros Ribeiro Dourado LP B, Santos M, Moreira-Gonçalves D. Nets, pulmonary arterial hypertension, and thrombo-inflammation. J Mol Med. 2022;100(5):713–722. doi:10.1007/s00109-022-02197-0
   PubMed Web of Science ®Google Scholar
• Li M, Riddle S, Kumar S, et al. Microenvironmental regulation of macrophage transcriptomic and metabolomic profiles in pulmonary hypertension. Front Immunol. 2021;12:640718. doi:10.3389/fimmu.2021.640718
   PubMed Web of Science ®Google Scholar
• Venosa A, Gow JG, Hall L, et al. Regulation of nitrogen mustard-induced lung macrophage activation by valproic acid, a histone deacetylase inhibitor. Toxicol Sci. 2017;157(1):222–234. doi:10.1093/toxsci/kfx032
   PubMed Web of Science ®Google Scholar
• Yaku A, Inagaki T, Asano R, et al. Regnase-1 prevents pulmonary arterial hypertension through mRNA degradation of interleukin-6 and platelet-derived growth factor in alveolar macrophages. Circulation. 2022;146(13):1006–1022. doi:10.1161/CIRCULATIONAHA.122.059435
   PubMed Web of Science ®Google Scholar
• Chi P-L, Cheng -C-C, Hung -C-C, et al. MMP-10 from M1 macrophages promotes pulmonary vascular remodeling and pulmonary arterial hypertension. Int J Biol Sci. 2022;18(1):331–348. doi:10.7150/ijbs.66472
   PubMed Web of Science ®Google Scholar
• Abid S, Marcos E, Parpaleix A, et al. CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension. Eur Respir J. 2019;54(4): doi:10.1183/13993003.02308-2018
   PubMed Web of Science ®Google Scholar
• Vaillancourt M, Ruffenach G, Meloche J, et al. Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension. Can J Cardiol. 2015;31(4):407–415. doi:10.1016/j.cjca.2014.10.023
   PubMed Web of Science ®Google Scholar
• Huertas A, Phan C, Bordenave J, et al. Regulatory T cell dysfunction in idiopathic, heritable and connective tissue-associated pulmonary arterial hypertension. Chest. 2016;149(6):1482–1493. doi:10.1016/j.chest.2016.01.004
   PubMed Web of Science ®Google Scholar